EcoR1 Capital, LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$1.4T
Holdings
48
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XNCRXENCOR INC | 4,547,072 | $147.3B | 10.88% | |
| 2 | PRTAPROTHENA CORP PLC | 9,426,640 | $98.6B | 7.28% | |
| 3 | ORICORIC PHARMACEUTICALS INC | 2,642,218 | $89.1B | 6.58% | |
| 4 | MORFMORPHIC HLDG INC | 2,837,973 | $76.8B | 5.67% | |
| 5 | KURAKURA ONCOLOGY INC | 4,608,529 | $75.1B | 5.55% | |
| 6 | ASMBASSEMBLY BIOSCIENCES INC | 3,153,797 | $73.5B | 5.43% | |
| 7 | —DICERNA PHARMACEUTICALS INC | 2,721,993 | $69.1B | 5.11% | |
| 8 | ANABANAPTYSBIO INC | 3,075,014 | $68.7B | 5.07% | |
| 9 | RNAAVIDITY BIOSCIENCES INC | 2,103,950 | $59.5B | 4.39% | |
| 10 | —NEOLEUKIN THERAPEUTICS INC | 3,536,684 | $58.7B | 4.34% | |
| 11 | RCUSARCUS BIOSCIENCES INC | 1,810,000 | $44.8B | 3.31% | |
| 12 | —AKOUOS INC | 1,975,984 | $44.5B | 3.28% | |
| 13 | GONGERON CORP | 19,230,769 | $41.9B | 3.10% | |
| 14 | MRTXEURMIRATI THERAPEUTICS INC | 357,849 | $40.9B | 3.02% | |
| 15 | RAREULTRAGENYX PHARMACEUTICAL IN | 519,119 | $40.6B | 3.00% | |
| 16 | —CONSTELLATION PHARMCETICLS I | 1,237,885 | $37.2B | 2.75% | Call |
| 17 | SURFUSDSURFACE ONCOLOGY INC | 5,033,861 | $33.0B | 2.44% | |
| 18 | BCELATRECA INC | 1,489,185 | $31.7B | 2.34% | |
| 19 | —APPLIED MOLECULAR TRANS INC | 1,150,000 | $28.9B | 2.14% | |
| 20 | FATEFATE THERAPEUTICS INC | 619,855 | $21.3B | 1.57% | |
| 21 | DNLIDENALI THERAPEUTICS INC | 733,561 | $17.7B | 1.31% | |
| 22 | BMY-RBRISTOL-MYERS SQUIBB CO | 4,748,300 | $17.0B | 1.26% | |
| 23 | —CYCLERION THERAPEUTICS INC | 2,742,276 | $16.2B | 1.20% | |
| 24 | FULCFULCRUM THERAPEUTICS INC | 882,353 | $16.1B | 1.19% | |
| 25 | CRNXCRINETICS PHARMACEUTICALS IN | 859,802 | $15.1B | 1.11% | |
| 26 | STROSUTRO BIOPHARMA INC | 1,828,492 | $14.2B | 1.05% | |
| 27 | RLMDRELMADA THERAPEUTICS INC | 200,000 | $8.9B | 0.66% | |
| 28 | KROSKEROS THERAPEUTICS INC | 220,216 | $8.3B | 0.61% | |
| 29 | GLYCEURGLYCOMIMETICS INC | 1,889,000 | $7.1B | 0.52% | |
| 30 | ACADACADIA PHARMACEUTICALS INC | 135,413 | $6.6B | 0.48% | |
| 31 | —EVELO BIOSCIENCES INC | 1,250,000 | $6.1B | 0.45% | |
| 32 | —PREVAIL THERAPEUTICS INC | 367,218 | $5.5B | 0.40% | |
| 33 | IRWDIRONWOOD PHARMACEUTICALS INC | 500,000 | $5.2B | 0.38% | Call |
| 34 | —EXICURE INC | 1,673,301 | $4.1B | 0.30% | |
| 35 | YB4PSAVARA INC | 1,432,664 | $3.6B | 0.26% | |
| 36 | —MAGENTA THERAPEUTICS INC | 450,000 | $3.4B | 0.25% | |
| 37 | —LIFESCI ACQUISITION CORP | 300,000 | $3.3B | 0.24% | |
| 38 | ACRSACLARIS THERAPEUTICS INC | 1,531,312 | $2.5B | 0.18% | |
| 39 | RPRXROYALTY PHARMA PLC | 50,000 | $2.4B | 0.18% | |
| 40 | —FIVE PRIME THERAPEUTICS INC | 379,945 | $2.3B | 0.17% | |
| 41 | CRVSCORVUS PHARMACEUTICALS INC | 737,612 | $2.0B | 0.15% | |
| 42 | RPTXREPARE THERAPEUTICS INC | 50,000 | $1.6B | 0.11% | |
| 43 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 25,300 | $1.2B | 0.09% | Call |
| 44 | MGTXMEIRAGTX HLDGS PLC | 94,819 | $1.2B | 0.09% | |
| 45 | XOMAXOMA CORP DEL | 50,809 | $1.0B | 0.07% | |
| 46 | KLDOKALEIDO BIOSCIENCES INC | 31,374 | $233.0M | 0.02% | |
| 47 | EQEQUILLIUM INC | 59,014 | $174.0M | 0.01% | |
| 48 | PLRXPLIANT THERAPEUTICS INC | 1,300 | $42.0M | 0.00% |